Other skin disorders

Even mild skin disease can cause significant distress for patients, due to associated visibility and stigma, and this is of particular relevance for conditions which affect

...


Read more on Other skin disorders

 

 

Latest news articles

Added 14 days ago Drug news

Settlement of litigation between Samsung Bioepis and AbbVie relating to adalimumab biosimilar,Imraldi.

AbbVie announced global resolution of all intellectual property-related litigation with Samsung Bioepis over its proposed biosimilar adalimumab product. Under the...

Added 1 month ago Drug news

DRM 01 fails two Phase III trials for treatment of acne.- Dermira Inc.

Dermira Inc. announced that DRM 01 ( olumacostat glasaretil) failed to meet its co-primary endpoints in two Phase III trials,...

Added 2 months ago Drug news

Phase III results show DRM 04 reduces impact and improves quality of life in pediatric hyperhidrosis.- Dermira.

Dermira has presented new findings from its DRM 04 (glycopyrronium tosylate) Phase III clinical program for pediatric patients (ages 9...

Search all news articles for Other skin disorders
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Psoriasis

Psoriasis

See information on psoriasis pathophysiology, signs and symptoms, comorbidities, treatment options, and more.

+ 2 more

Chronic Spontaneous Urticaria (CSU)

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria.

+ 7 more

IL-17A in Psoriasis

IL-17A in Psoriasis

Experts discuss new targeted therapies for psoriasis at the European Association of Dermatology and Venereology (EADV) Congress.

+ 1 more

Fabry Disease

Fabry Disease

Explore the pathophysiology and treatment options for Fabry disease, a deficiency of the lysosomal enzyme alpha-galactosidase A

Load more

Guidelines

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017

The overall aim of the guideline is to provide evidence-based recommendations on the use of biologic therapies (adalimumab, etanercept, infliximab, ixekizumab, secukinumab and ustekinumab) in adults, children and young people...

Added 8 years ago

British Association of Dermatologists’ guidelines for the care of patients with actinic keratosis 2017

The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of actinic keratosis (AK).

Added 1 month ago

Canadian Guidelines for the Management of Plaque Psoriasis 2009

Since the publication of the 2009 Canadian Guidelines for the Management of Plaque Psoriasis, significant advances have been made in determining the role of T cells in inflammatory and autoimmune diseases. 

Added 1 year ago

Search all guidelines for Other skin disorders
 

Journal articles

A novel nicastrin mutation in a three generation Dutch family with hidradenitis suppurativa

Hidradenitis suppurativa (HS) compromises a multifactorial pathogenesis with a largely unclear aetiology. 

Added 9 months ago

Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa

Introduction: Hidradenitis suppurativa (HS) is a serious, debilitating, chronic inflammatory skin disease. Adalimumab is a fully human, immunoglobulin G1 monoclonal antibody specific for tumor necrosis factor-alpha...

Added 9 months ago

Search all journal articles for Other skin disorders
 

Clinical trials

Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects (HS rPMS)

The objective of this study is to evaluate the safety profile of Adalimumab for Hidradenitis Suppurativa (HS) participants in normal medical practice.

Added 1 year ago

Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting - HARMONY Study

This study will assess the effects of adalimumab treatment in moderate to severe Hidradenitis Suppurativa (HS) patients in the real world setting.

Added 1 year ago

Safety and Efficacy of Humira (Adalimumab) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS Study) (SHARPS)

The objective of this study is to assess the safety and efficacy of adalimumab prior to surgery in subjects with moderate to severe Hidradenitis Suppurativa (HS) who are surgical candidates.

Added 1 year ago

Search all clinical trials for Other skin disorders
 
Liam Farrell

Dr Liam Farrell is from Rostrevor in Northern Ireland. He was a family doctor in Crossmaglen, Northern Ireland and a tutor in palliative care. An award-winning satirical columnist and broadcaster, his current columns include the British Medical Journal and GP. He is a member of the ... Read more

Bad smells are good

Delicacy is not a virtue in this job.

CME

Emergencies in dermatology

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0

EAACI 2017: The future of urticaria – advances in CSU research

EAACI 2017: The future of urticaria – advances in CSU research
Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
FREE

Management of hidradenitis suppurativa

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Other skin disorders